EP2502620A1 — Solid pharmaceutical composition comprising donepezil
Assigned to KRKA dd · Expires 2012-09-26 · 14y expired
What this patent protects
The present invention relates to a solid pharmaceutical composition comprising (a) at least one drug selected from donepezil or a pharmaceutically acceptable salt or solvate thereof and (b) at least one matrix former which is selected from the group consisting of cellulose deriva…
USPTO Abstract
The present invention relates to a solid pharmaceutical composition comprising (a) at least one drug selected from donepezil or a pharmaceutically acceptable salt or solvate thereof and (b) at least one matrix former which is selected from the group consisting of cellulose derivatives, starch derivatives and mixtures thereof, wherein the matrix former has a viscosity of 80 to 120,000 mPa·s, determined for a 2 % (w/v) aqueous solution at 20°C, as well as a process for its preparation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.